Glenview Trust Co bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 381,609 shares of the company’s stock, valued at approximately $49,037,000.
A number of other institutional investors have also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC bought a new position in Merck KGaA during the 2nd quarter worth about $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at about $27,000. Solstein Capital LLC bought a new stake in shares of Merck KGaA in the second quarter valued at about $33,000. Delos Wealth Advisors LLC bought a new stake in shares of Merck KGaA in the second quarter valued at about $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA during the second quarter worth about $39,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of MKGAF opened at $158.15 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The stock has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. The company has a 50 day moving average of $163.21 and a 200-day moving average of $148.95.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
